It is possible, however, that the augmented expression of PPARα in AD cortex is not sufficient per se to exert efficient neuroprotective and anti-inflammatory actions, since the available endogenous ligands may be present at very low concentrations (Roy et al., 2016). The gene discussed is PPARA; the disease is Alzheimer disease.